David R Epstein - Net Worth and Insider Trading
David R Epstein Net Worth
The estimated net worth of David R Epstein is at least $32 Million dollars as of 2024-11-05. David R Epstein is the CEO of Seagen Inc and owns about 136,598 shares of Seagen Inc (SGEN) stock worth over $31 Million. David R Epstein is the Director of Rubius Therapeutics Inc and owns about 4,720,012 shares of Rubius Therapeutics Inc (RUBY) stock worth over $269,041. David R Epstein is also the Director of Axcella Health Inc and owns about 6,446 shares of Axcella Health Inc (AXLA) stock worth over $2,584. Besides these, David R Epstein also holds Evelo Biosciences Inc (EVLO) . Details can be seen in David R Epstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David R Epstein has not made any transactions after 2023-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David R Epstein
David R Epstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David R Epstein owns 8 companies in total, including Evelo Biosciences Inc (EVLO) , Axcella Health Inc (AXLA) , and Rubius Therapeutics Inc (RUBY) among others .
Click here to see the complete history of David R Epstein’s form 4 insider trades.
Insider Ownership Summary of David R Epstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EVLO | Evelo Biosciences Inc | 2022-05-27 | director |
| AXLA | Axcella Health Inc | 2022-03-16 | director |
| RUBY | Rubius Therapeutics Inc | 2022-04-21 | director |
 | | 2016-01-01 | director |
| | 2021-05-25 | director |
| | 2021-10-26 | director |
| | 2021-05-25 | director |
| | 2023-11-10 | director & Chief Executive Officer |
David R Epstein Latest Holdings Summary
David R Epstein currently owns a total of 4 stocks. Among these stocks, David R Epstein owns 136,598 shares of Seagen Inc (SGEN) as of November 10, 2023, with a value of $31 Million and a weighting of 99.14%. David R Epstein owns 4,720,012 shares of Rubius Therapeutics Inc (RUBY) as of April 21, 2022, with a value of $269,041 and a weighting of 0.85%. David R Epstein also owns 6,446 shares of Axcella Health Inc (AXLA) as of March 16, 2022, with a value of $2,584 and a weighting of 0.01%. The other 1 stocks Evelo Biosciences Inc (EVLO) have a combined weighting of 0% among all his current holdings.
Latest Holdings of David R Epstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2023-11-10 | 136,598 | 228.74 | 31,245,427 |
| RUBY | Rubius Therapeutics Inc | 2022-04-21 | 4,720,012 | 0.06 | 269,041 |
| AXLA | Axcella Health Inc | 2022-03-16 | 6,446 | 0.40 | 2,584 |
| EVLO | Evelo Biosciences Inc | 2022-05-27 | 4,204 | 0.00 | 2 |
Holding Weightings of David R Epstein
David R Epstein Form 4 Trading Tracker
According to the SEC Form 4 filings, David R Epstein has made a total of 1 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Seagen Inc is the sale of 10,620 shares on November 10, 2023, which brought David R Epstein around $2 Million.
According to the SEC Form 4 filings, David R Epstein has made a total of 5 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in Rubius Therapeutics Inc is the acquisition of 30,000 shares on April 21, 2022, which cost David R Epstein around $43,200.
According to the SEC Form 4 filings, David R Epstein has made a total of 5 transactions in Axcella Health Inc (AXLA) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Axcella Health Inc is the acquisition of 1,047 shares on March 16, 2022, which cost David R Epstein around $50,000.
More details on David R Epstein's insider transactions can be found in the Insider Trading History of David R Epstein table.Insider Trading History of David R Epstein
- 1
David R Epstein Trading Performance
GuruFocus tracks the stock performance after each of David R Epstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David R Epstein is 3.11%. GuruFocus also compares David R Epstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by David R Epstein within 3 months outperforms 8 times out of 17 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David R Epstein's insider trading performs compared to the benchmark.
Performance of David R Epstein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.51 | | | | | |
| Relative Return to S&P 500(%) | 4.81 | | | | | |
David R Epstein Ownership Network
Ownership Network List of David R Epstein
Ownership Network Relation of David R Epstein
David R Epstein Owned Company Details
What does Evelo Biosciences Inc do?
Who are the key executives at Evelo Biosciences Inc?
David R Epstein is the director of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , Chief Financial Officer Marella Thorell , and See Remarks Mark Bodmer .
Evelo Biosciences Inc (EVLO) Insider Trades Summary
Over the past 18 months, David R Epstein made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 103,730 shares made by Mark Bodmer , a net sale of 80,121 shares made by Duncan Mchale , and a net sale of 46,345 shares made by Marella Thorell .
In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 46,829 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,364,426 shares.
Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evelo Biosciences Inc Insider Transactions
David R Epstein Mailing Address
Above is the net worth, insider trading, and ownership report for David R Epstein. You might contact David R Epstein via mailing address: International Flavors & Fragrances Inc., 521 W. 57th Street, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
